BioStem Technologies, Inc. (BSEM) News
Track canonical SquawkNews coverage tagged to BSEM, BioStem Technologies, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BioStem Technologies Inc. (BSEM) Prices $3M Private Placement With Warrants
BioStem Technologies priced a ~$3M private placement of 735,296 shares at $4.08 with Series A and B warrants (exercise $3.83). Warrants are immediately exercisable; A expire 5 years after resale registration effectivenes
EQUITY | Sep 30, 2026, 12:09 PM UTC
L
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
POMPANO BEACH, Fla., Sept. 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. NASDAQ:BSEM (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercia
NEWS | Sep 30, 2026, 12:08 PM UTC
L
BSEM - Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
BSEM - Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
NEWS | Sep 21, 2026, 08:30 PM UTC
M
BioStem Technologies gets up to $40M committed equity facility
BioStem Technologies said it entered a committed equity facility for up to $40 million.
EQUITY | Sep 18, 2026, 11:02 AM UTC
L
BSEM - BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
BSEM - BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
NEWS | Sep 18, 2026, 11:00 AM UTC
L
BioStem adds hospital access for VENDAJE products via Vizient and Premier
BioStem Technologies said additions extend its hospital channel to its BioRetain wound care line, opening hospital access for VENDAJE® and VENDAJE AC® through Vizient and Premier.
EQUITY | Sep 04, 2026, 11:07 AM UTC
L
BioStem Technologies opens hospital access for VENDAJE® via Vizient and Premier
BioStem Technologies says it has opened hospital access for VENDAJE® and VENDAJE AC® through Vizient and Premier.
EQUITY | Sep 04, 2026, 11:00 AM UTC
L
BioStem Technologies to present at H.C. Wainwright global investment conference
BioStem Technologies Inc. (BSEM) said it will present at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 03, 2026, 08:07 PM UTC
L
BioStem Technologies to present at H.C. Wainwright conference
BioStem Technologies says it will present at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 03, 2026, 08:06 PM UTC
L
BSEM - BioStem Technologies to Present at the Sidoti MicroCap Conference
BSEM - BioStem Technologies to Present at the Sidoti MicroCap Conference
EQUITY | Aug 14, 2026, 08:05 PM UTC
L
BSEM Reports Q2 2026 Financial Results
BioStem Technologies reports second quarter 2026 financial results
EARNINGS | Aug 12, 2026, 08:08 PM UTC
L
BioStem files registration statement with SEC, to pursue Nasdaq listing
BioStem Technologies announced the filing of a Form 10 registration statement with the SEC to register its shares of common stock pursuant to the Securities Exchange Act of 1934, as amended, and reaffirmed its strategic
EQUITY | Jul 10, 2026, 11:07 AM UTC